# MSRA

## Overview
The MSRA gene encodes the enzyme methionine sulfoxide reductase A, a critical component in cellular defense against oxidative stress. This enzyme belongs to the oxidoreductase family and is responsible for the reduction of methionine sulfoxide back to methionine, thereby repairing oxidatively damaged proteins and maintaining cellular homeostasis (Hansel2005Heterogeneity; Sreekumar2011Methionine). Methionine sulfoxide reductase A is characterized by a thioredoxin-like fold and a unique structural motif that facilitates its catalytic function (Lowther2000Structure; Lee2014Structural). The enzyme is ubiquitously expressed in various cellular compartments, including the cytosol, mitochondria, and nucleus, and plays a significant role in modulating oxidative stress responses and protein interactions (Fu2017Methionine; Sreekumar2011Methionine). MSRA's activity is crucial for cellular protection against oxidative damage, and its dysfunction is implicated in several diseases, including neurodegenerative disorders and cancer (De2010Methionine; Reiterer2019Methionine).

## Structure
The methionine sulfoxide reductase A (MSRA) protein is characterized by a unique molecular structure that includes a central core of approximately 140 amino acids. This core is composed of a rolled mixed beta-sheet flanked by three alpha-helices, along with a short alpha-helix and two antiparallel beta-strands, forming a distinct fold with no significant homology to other protein families (Kauffmann2005The). The active site of MSRA is organized around a catalytic cysteine residue, Cys51, which is crucial for its function. This site is surrounded by conserved amino acids that form a large open basin, facilitating the binding of bulky protein substrates (Kauffmann2005The).

The enzyme's structure includes a conserved Gly-Cys-Phe-Trp-Gly motif, with the cysteine residue playing a pivotal role in the catalytic mechanism (Lowther2000Structure). MSRA is monomeric in solution, consistent with other characterized MsrAs, and features a thioredoxin-like fold (Lee2014Structural). The protein undergoes conformational changes during its catalytic cycle, which are necessary for the formation of disulfide bonds between cysteine residues (Coudevylle2007Solution). These structural features contribute to the enzyme's ability to repair oxidized methionine residues in proteins.

## Function
The MSRA gene encodes the enzyme methionine sulfoxide reductase A, which plays a crucial role in protecting cells from oxidative stress by reducing methionine sulfoxide back to methionine. This reduction process is vital for repairing proteins damaged by oxidation, thereby maintaining protein function and cellular homeostasis (Hansel2005Heterogeneity; Sreekumar2011Methionine). MSRA is active in various cellular compartments, including the cytosol, mitochondria, and nucleus, with different isoforms localizing to these areas (Hansel2005Heterogeneity; Sreekumar2011Methionine).

In healthy human cells, MSRA contributes to the antioxidant response by engaging in cycles of methionine oxidation and reduction, which helps scavenge reactive oxygen species (ROS) and protect against oxidative damage (Sreekumar2011Methionine). The enzyme's activity is facilitated by two active-site cysteine residues essential for its function (Sreekumar2011Methionine). MSRA is particularly abundant in tissues such as the retina and retinal pigment epithelium, where it helps protect against oxidative damage (Sreekumar2011Methionine).

MSRA's protective effects extend to preserving mitochondrial function and inhibiting caspase activation, which enhances cell survival under oxidative stress conditions (Sreekumar2011Methionine). Its role in reducing oxidative stress and interaction with other proteins makes it a potential target for therapeutic strategies to prevent degenerative diseases (Sreekumar2011Methionine).

## Clinical Significance
Mutations and altered expression of the MSRA gene have been implicated in several neurological and metabolic disorders. In schizophrenia, MSRA is associated with oxidative stress and may interact with dopamine-related genes such as DRD2 and COMT, influencing dopamine function and behavior. Genetic variants of MSRA may also increase the risk of schizophrenia when combined with ischemia-hypoxia conditions (Reiterer2019Methionine). In Alzheimer's disease, MSRA dysfunction is linked to increased oxidative stress, decreased enzyme activity, and the accumulation of amyloid-beta plaques, contributing to neurodegeneration (Jiang2018The; Reiterer2019Methionine). In Parkinson's disease, MSRA appears to protect dopaminergic neurons, and its absence can lead to increased methionine oxidation, affecting protein function and contributing to disease pathology (Jiang2018The; Reiterer2019Methionine).

In breast cancer, down-regulation of MSRA is associated with increased tumor aggressiveness, higher levels of reactive oxygen species, and activation of pathways that promote cell proliferation and invasion (De2010Methionine). MSRA's role in modulating oxidative stress and signal transduction pathways suggests its potential as a therapeutic target in these conditions (Moskovitz2021Methionine).

## Interactions
Methionine sulfoxide reductase A (MSRA) is involved in various protein interactions that are crucial for its function in cellular processes. In the context of oxidative stress, MSRA interacts with proteins involved in the ubiquitin-like protein modification system in archaea, such as Orc3 and Cdc48d, through a process known as sampylation. This interaction is specific to the presence of functional MSRA and involves the attachment of small archaeal modifier proteins (SAMPs) to target proteins (Fu2017Methionine).

In mammals, MSRA is implicated in the ubiquitination of the 14-3-3 zeta protein, which plays a role in dopamine synthesis and alpha synuclein degradation in the brain. The absence of MSRA leads to increased levels of 14-3-3 zeta and dopamine (Moskovitz2021Methionine). MSRA also interacts with Jab1, enhancing its deneddylase activity, which affects cell survival by regulating the expression of the cell cycle inhibitor P27 (Moskovitz2021Methionine).

These interactions highlight the role of MSRA in modulating protein function and stability, particularly under conditions of oxidative stress, and underscore its importance in cellular resistance to oxidative damage and regulation of signal transduction pathways.


## References


[1. (Jiang2018The) Beichen Jiang and Jackob Moskovitz. The functions of the mammalian methionine sulfoxide reductase system and related diseases. Antioxidants, 7(9):122, September 2018. URL: http://dx.doi.org/10.3390/antiox7090122, doi:10.3390/antiox7090122. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/antiox7090122)

[2. (Kauffmann2005The) Brice Kauffmann, André Aubry, and Frédérique Favier. The three-dimensional structures of peptide methionine sulfoxide reductases: current knowledge and open questions. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1703(2):249–260, January 2005. URL: http://dx.doi.org/10.1016/j.bbapap.2004.09.008, doi:10.1016/j.bbapap.2004.09.008. This article has 37 citations.](https://doi.org/10.1016/j.bbapap.2004.09.008)

[3. (Lowther2000Structure) W. Todd Lowther, Nathan Brot, Herbert Weissbach, and Brian W. Matthews. Structure and mechanism of peptide methionine sulfoxide reductase, an “anti-oxidation” enzyme,. Biochemistry, 39(44):13307–13312, October 2000. URL: http://dx.doi.org/10.1021/bi0020269, doi:10.1021/bi0020269. This article has 126 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi0020269)

[4. (Lee2014Structural) Eun Hye Lee, Geun-Hee Kwak, Moon-Jung Kim, Hwa-Young Kim, and Kwang Yeon Hwang. Structural analysis of 1-cys type selenoprotein methionine sulfoxide reductase a. Archives of Biochemistry and Biophysics, 545:1–8, March 2014. URL: http://dx.doi.org/10.1016/j.abb.2013.12.024, doi:10.1016/j.abb.2013.12.024. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.abb.2013.12.024)

[5. (Fu2017Methionine) Xian Fu, Zachary Adams, Rui Liu, Nathaniel L. Hepowit, Yifei Wu, Connor F. Bowmann, Jackob Moskovitz, and Julie A. Maupin-Furlow. Methionine sulfoxide reductase a (msra) and its function in ubiquitin-like protein modification in archaea. mBio, November 2017. URL: http://dx.doi.org/10.1128/mbio.01169-17, doi:10.1128/mbio.01169-17. This article has 20 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mbio.01169-17)

[6. (Moskovitz2021Methionine) Jackob Moskovitz and Adam Smith. Methionine sulfoxide and the methionine sulfoxide reductase system as modulators of signal transduction pathways: a review. Amino Acids, 53(7):1011–1020, June 2021. URL: http://dx.doi.org/10.1007/s00726-021-03020-9, doi:10.1007/s00726-021-03020-9. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00726-021-03020-9)

[7. (Sreekumar2011Methionine) Parameswaran G Sreekumar. Methionine sulfoxide reductase a: structure, function and role in ocular pathology. World Journal of Biological Chemistry, 2(8):184, 2011. URL: http://dx.doi.org/10.4331/wjbc.v2.i8.184, doi:10.4331/wjbc.v2.i8.184. This article has 22 citations.](https://doi.org/10.4331/wjbc.v2.i8.184)

[8. (Hansel2005Heterogeneity) Alfred Hansel, Stefan H. Heinemann, and Toshinori Hoshi. Heterogeneity and function of mammalian msrs: enzymes for repair, protection and regulation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 1703(2):239–247, January 2005. URL: http://dx.doi.org/10.1016/j.bbapap.2004.09.010, doi:10.1016/j.bbapap.2004.09.010. This article has 77 citations.](https://doi.org/10.1016/j.bbapap.2004.09.010)

[9. (De2010Methionine) Antonella De Luca, Fabio Sanna, Michele Sallese, Carmen Ruggiero, Mauro Grossi, Paolo Sacchetta, Cosmo Rossi, Vincenzo De Laurenzi, Carmine Di Ilio, and Bartolo Favaloro. Methionine sulfoxide reductase a down-regulation in human breast cancer cells results in a more aggressive phenotype. Proceedings of the National Academy of Sciences, 107(43):18628–18633, October 2010. URL: http://dx.doi.org/10.1073/pnas.1010171107, doi:10.1073/pnas.1010171107. This article has 79 citations.](https://doi.org/10.1073/pnas.1010171107)

[10. (Coudevylle2007Solution) Nicolas Coudevylle, Mathias Antoine, Sabine Bouguet-Bonnet, Pierre Mutzenhardt, Sandrine Boschi-Muller, Guy Branlant, and Manh-Thong Cung. Solution structure and backbone dynamics of the reduced form and an oxidized form of e. coli methionine sulfoxide reductase a (msra): structural insight of the msra catalytic cycle. Journal of Molecular Biology, 366(1):193–206, February 2007. URL: http://dx.doi.org/10.1016/J.JMB.2006.11.042, doi:10.1016/j.jmb.2006.11.042. This article has 35 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/J.JMB.2006.11.042)

[11. (Reiterer2019Methionine) Melissa Reiterer, Rainald Schmidt-Kastner, and Sarah L. Milton. Methionine sulfoxide reductase (msr) dysfunction in human brain disease. Free Radical Research, 53(11–12):1144–1154, November 2019. URL: http://dx.doi.org/10.1080/10715762.2019.1662899, doi:10.1080/10715762.2019.1662899. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/10715762.2019.1662899)